Kanał NAOV
NA

NanoVibronix, Inc.

NAOV · NASDAQ

$1.90 +1.06% (+$0.02)
Piotroski F-Score Weak
0/9
Valuation
-
N/A
P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A
EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A
Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A
ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Stability
0 /100
Unstable
Beta 2.06x
Rev. volatility N/A
Profitable years N/A

Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej

Zapytaj StockBota o NAOV
Online

O spółce

NanoVibronix (NVCN) is a company focused on the development and commercialization of innovative medical devices utilizing ultrasound technology. With a product portfolio including PainShield®, NanoVibronix is a pioneer in the field of ultrasound therapy for the treatment of various conditions and ailments. PainShield® is a portable device designed to treat pain and inflammation using ultrasound vibrations applied to the affected area. The company also focuses on other applications of ultrasound technology in areas such as regenerative therapies, drainage procedures, and infection prevention. With growing interest in non-invasive therapeutic methods and the need for innovative treatment approaches, NanoVibronix has the potential for further development and expansion in the market. NanoVibronix (NVCN) shares could be suitable for investors seeking exposure in the medical technology field with a focus on ultrasound therapy and innovative treatment approaches.

Opis nie jest jeszcze dostępny w Twoim języku, więc tekst jest po angielsku.

Sector

Healthcare

Industry

Medical - Devices

CEO

Doron Robert Besser

Employees

31

Headquarters

Elmsford

Używamy niezbędnych plików cookie do działania strony oraz opcjonalnych analitycznych plików cookie do pomiaru ruchu. Zobacz naszą Politykę prywatności.